Premium
Immunological definition of acute promyelocyte leukemia (FAB M3): A study of 39 cases
Author(s) -
Rossi G.,
Avvisati G.,
Coluzzi S.,
Fenu S.,
LoCoco F.,
Lopez M.,
Nanni M.,
Pasqualetti D.,
Mandelli F.
Publication year - 1990
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1990.tb00446.x
Subject(s) - acute promyelocytic leukemia , promyelocyte , leukemia , acute leukemia , medicine , phenotype , antigen , immunology , monoclonal antibody , gene rearrangement , biology , antibody , gene , genetics , retinoic acid
Acute promyelocytic leukemia (FAB‐M3) is a distinct entity among acute non‐lymphoid leukemias (ANLL) with peculiar morphological, biological, clinical and prognostic features. An atypical form of M3 (M3v) could be confused with other FAB ANLL and therefore the diagnosis of this variant requires ultrastructural analysis and/or cytogenetic study and/or selective gene rearrangement studies. The immunological phenotype of blast cells in 39 APL patients was studied at diagnosis. The diagnosis of M3 FAB type was ascertained in 32 and the diagnosis of M3v in 7 cases. Using a large series of monoclonal antibodies (mAb), the APL blast cells were B and T cell antigens‐negative, HLA‐DR constantly negative, CD 13‐ and/or CD33‐positive, CD9‐positive. Among ANLL this phenotype seems to be closely related to APL both in M3 type and M3v subtype. Because the diagnosis of APL (M3 or M3v) is important in order to establish the specific therapeutic approach, the discriminant capacity of the immunological typing to identify M3 and mainly M3v (hypogranular) could be determinant for a “quick” diagnosis.